TY - JOUR
T1 - Prognostic Value of Megatroponinemia After Myocardial Infarction
AU - Kalra, Nishant
AU - Sattur, Sudhakar
AU - Sorrell, Vincent L.
PY - 2009/4
Y1 - 2009/4
N2 - Purpose: The purpose of this study is to investigate the prognostic value of megatroponinemia (troponins >100 ng/mL), as a predictor of major adverse cardiac events such as recurrent angina, myocardial infarction, and death in patients presenting with acute myocardial infarction. Methods: Over a period of 2 years, we identified 27 patients admitted with acute myocardial infarction and troponin I values >100 ng/mL. These patients were followed-up for the short term during their hospitalization as well as for an intermediate term of 18 ± 14 months after their initial presentation with acute myocardial infarction for major adverse cardiac events including recurrent angina, myocardial infarction, and death. Results: Of the 27 patients, one died 5 days after myocardial infarction and 26 were discharged home in stable condition, with few requiring timely intervention. Six patients were lost to follow-up. Five patients died during follow-up, 4 from recurrent myocardial infarction and 1 died from metastatic renal cell carcinoma. Twelve patients had non-fatal myocardial infarction, with 10 being acute ST elevation; 3 patients had recurrent angina. Conclusion: Patients presenting with an acute myocardial infarction and troponins >100 ng/mL have continued incremental risk of excessive major adverse cardiac events during short and intermediate follow-up period.
AB - Purpose: The purpose of this study is to investigate the prognostic value of megatroponinemia (troponins >100 ng/mL), as a predictor of major adverse cardiac events such as recurrent angina, myocardial infarction, and death in patients presenting with acute myocardial infarction. Methods: Over a period of 2 years, we identified 27 patients admitted with acute myocardial infarction and troponin I values >100 ng/mL. These patients were followed-up for the short term during their hospitalization as well as for an intermediate term of 18 ± 14 months after their initial presentation with acute myocardial infarction for major adverse cardiac events including recurrent angina, myocardial infarction, and death. Results: Of the 27 patients, one died 5 days after myocardial infarction and 26 were discharged home in stable condition, with few requiring timely intervention. Six patients were lost to follow-up. Five patients died during follow-up, 4 from recurrent myocardial infarction and 1 died from metastatic renal cell carcinoma. Twelve patients had non-fatal myocardial infarction, with 10 being acute ST elevation; 3 patients had recurrent angina. Conclusion: Patients presenting with an acute myocardial infarction and troponins >100 ng/mL have continued incremental risk of excessive major adverse cardiac events during short and intermediate follow-up period.
KW - Acute myocardial infarction
KW - Megatroponinemia
KW - Prognosis
KW - Troponin
UR - http://www.scopus.com/inward/record.url?scp=63049139285&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=63049139285&partnerID=8YFLogxK
U2 - 10.1016/j.amjmed.2008.11.024
DO - 10.1016/j.amjmed.2008.11.024
M3 - Article
C2 - 19332235
AN - SCOPUS:63049139285
SN - 0002-9343
VL - 122
SP - 392
EP - 394
JO - American Journal of Medicine
JF - American Journal of Medicine
IS - 4
ER -